carbon monoxide has been researched along with Cardiomyopathy, Hypertrophic in 1 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
Cardiomyopathy, Hypertrophic: A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Knaapen, P | 1 |
van Dockum, WG | 1 |
Bondarenko, O | 1 |
Kok, WE | 1 |
Götte, MJ | 1 |
Boellaard, R | 1 |
Beek, AM | 1 |
Visser, CA | 1 |
van Rossum, AC | 1 |
Lammertsma, AA | 1 |
Visser, FC | 1 |
1 other study available for carbon monoxide and Cardiomyopathy, Hypertrophic
Article | Year |
---|---|
Delayed contrast enhancement and perfusable tissue index in hypertrophic cardiomyopathy: comparison between cardiac MRI and PET.
Topics: Adult; Aged; Carbon Monoxide; Cardiomyopathy, Hypertrophic; Case-Control Studies; Chronic Disease; F | 2005 |